Published in Toxicol Sci on January 23, 2017
Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity (2000) 6.97
The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J Exp Med (1988) 2.23
Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol (2006) 2.18
Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology (2009) 2.11
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology (2008) 2.05
Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans. Environ Health Perspect (2009) 1.94
Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice. J Thromb Haemost (2014) 1.54
Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology (2008) 1.45
Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology (1996) 1.41
Human health effects of trichloroethylene: key findings and scientific issues. Environ Health Perspect (2012) 1.34
Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology (2008) 1.30
Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur J Immunol (1995) 1.26
B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology (2008) 1.17
Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun (2012) 1.16
Trichloroethene-induced autoimmune response in female MRL +/+ mice. Toxicol Appl Pharmacol (1995) 1.15
CD4(+) T-cell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+/+ mice. Toxicol Sci (2000) 1.13
Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology (2000) 1.12
Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop. J Autoimmun (2012) 1.05
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat Commun (2015) 1.04
B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice. Hepatology (2009) 1.03
Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells. J Autoimmun (2014) 1.02
Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Rα(-/-) mice. J Autoimmun (2014) 1.00
Liver immunology. Compr Physiol (2013) 0.99
The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice. Hepatology (2012) 0.98
Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice. Hepatology (2013) 0.98
Criteria for environmentally associated autoimmune diseases. J Autoimmun (2012) 0.95
The limitations and hidden gems of the epidemiology of primary biliary cirrhosis. J Autoimmun (2013) 0.94
In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes. J Immunol (1995) 0.93
Genetics in PBC: what do the "risk genes" teach us? Clin Rev Allergy Immunol (2015) 0.91
Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10/Idd18) mice. Clin Exp Immunol (2014) 0.91
Animal models of primary biliary cirrhosis. Clin Rev Allergy Immunol (2015) 0.90
Genome-Wide Association Studies in Primary Biliary Cirrhosis. Semin Liver Dis (2015) 0.90
TRICHLOROETHYLENE, TETRACHLOROETHYLENE, AND SOME OTHER CHLORINATED AGENTS. IARC Monogr Eval Carcinog Risks Hum (2014) 0.90
Inhibition of CYP2E1 reverses CD4+ T-cell alterations in trichloroethylene-treated MRL+/+ mice. Toxicol Sci (2000) 0.90
Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis. J Autoimmun (2015) 0.90
Animal models of primary biliary cirrhosis. Semin Liver Dis (2014) 0.89
Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. J Autoimmun (2010) 0.88
Immunity, tolerance and autoimmunity in the liver: A comprehensive review. J Autoimmun (2015) 0.86
Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance. Hepatology (2016) 0.86
Animal models of primary biliary cirrhosis: materials and methods. Methods Mol Biol (2012) 0.86
Liver auto-immunology: the paradox of autoimmunity in a tolerogenic organ. J Autoimmun (2013) 0.85
Unmet challenges in immune-mediated hepatobiliary diseases. Clin Rev Allergy Immunol (2015) 0.85
Delineating liver events in trichloroethylene-induced autoimmune hepatitis. Chem Res Toxicol (2009) 0.85
Animal models in primary biliary cirrhosis and primary sclerosing cholangitis. Clin Rev Allergy Immunol (2015) 0.84
Pesticides, chemical and industrial exposures in relation to systemic lupus erythematosus. Lupus (2014) 0.84
Multiple genetic variants associated with primary biliary cirrhosis in a Han Chinese population. Clin Rev Allergy Immunol (2015) 0.82
Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity. Clin Rev Allergy Immunol (2016) 0.82
AAV-IL-22 modifies liver chemokine activity and ameliorates portal inflammation in murine autoimmune cholangitis. J Autoimmun (2015) 0.81
Xenobiotic exposure and autoimmune hepatitis. Hepat Res Treat (2010) 0.80
Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy. J Autoimmun (2015) 0.80
Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis. Int J Exp Pathol (2014) 0.79
Cutting edge issues in autoimmune hepatitis. J Autoimmun (2016) 0.79
Trichloroethylene Does Not Accelerate Autoimmune Diabetes in NOD Mice. J Immunotoxicol (2005) 0.78
Beta-glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis. Clin Exp Immunol (2009) 0.78
Adaptive immunity in the liver. Cell Mol Immunol (2016) 0.78
Chronic exposure to water pollutant trichloroethylene increased epigenetic drift in CD4(+) T cells. Epigenomics (2016) 0.78
A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis. Expert Rev Mol Diagn (2016) 0.78
Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice. Clin Exp Immunol (2016) 0.76
The epigenetics of PBC: The link between genetic susceptibility and environment. Clin Res Hepatol Gastroenterol (2016) 0.76